Hyliion (NYSE: HYLN) holder files Rule 144 notice to sell 30,000 shares
Rhea-AI Filing Summary
A shareholder of Hyliion Holdings Corp has filed a notice of proposed sale under Rule 144 covering 30,000 shares of common stock. The shares are to be sold through UBS Financial Services Inc. on the NYSE, with an indicated aggregate market value of $58,500. The filing notes that the issuer has 175,400,000 shares of this class outstanding. The seller acquired the 30,000 shares on 12/12/2025 in an employee benefit transaction from Hyliion Holdings Corp and paid for them in cash on the same date.
Positive
- None.
Negative
- None.
FAQ
What does the Hyliion (HYLN) Rule 144 filing disclose?
The filing discloses a planned sale of 30,000 Hyliion Holdings Corp common shares under Rule 144 by a shareholder through UBS Financial Services Inc. on the NYSE.
How many Hyliion (HYLN) shares are planned to be sold and at what market value?
The shareholder plans to sell 30,000 common shares with an indicated aggregate market value of $58,500.
When were the Hyliion (HYLN) shares acquired and how were they obtained?
The 30,000 shares were acquired on 12/12/2025 in an employee benefit transaction from Hyliion Holdings Corp, with payment in cash on the same date.
How many Hyliion (HYLN) shares are outstanding according to this notice?
The notice states that there are 175,400,000 shares of Hyliion common stock outstanding.
Which broker and exchange are involved in this Hyliion (HYLN) share sale?
The proposed sale is to be executed through UBS Financial Services Inc. on the NYSE.
What representation does the selling shareholder make about Hyliion (HYLN)?
The selling shareholder represents that they do not know of any material adverse information about Hyliion’s current or prospective operations that has not been publicly disclosed.